Cases and Research Letters
Cutaneous CD8+ T-cell Infiltrates Associated With Human Immunodeficiency Virus
Infiltración cutánea por linfocitos T CD8+ asociada a virus de la inmunodeficiencia humana
Leído
8602
Vecesse ha leído el artículo
2486
Total PDF
6116
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 16 | 3 | 19 |
| 2025 5 | 131 | 30 | 161 |
| 2025 4 | 150 | 22 | 172 |
| 2025 3 | 116 | 27 | 143 |
| 2025 2 | 118 | 35 | 153 |
| 2025 1 | 80 | 25 | 105 |
| 2024 12 | 71 | 29 | 100 |
| 2024 11 | 92 | 66 | 158 |
| 2024 10 | 65 | 46 | 111 |
| 2024 9 | 65 | 31 | 96 |
| 2024 8 | 95 | 71 | 166 |
| 2024 7 | 71 | 39 | 110 |
| 2024 6 | 93 | 52 | 145 |
| 2024 5 | 77 | 36 | 113 |
| 2024 4 | 78 | 25 | 103 |
| 2024 3 | 79 | 32 | 111 |
| 2024 2 | 80 | 26 | 106 |
| 2024 1 | 75 | 38 | 113 |
| 2023 12 | 75 | 19 | 94 |
| 2023 11 | 70 | 30 | 100 |
| 2023 10 | 50 | 26 | 76 |
| 2023 9 | 66 | 31 | 97 |
| 2023 8 | 37 | 17 | 54 |
| 2023 7 | 61 | 31 | 92 |
| 2023 6 | 52 | 17 | 69 |
| 2023 5 | 70 | 31 | 101 |
| 2023 4 | 48 | 20 | 68 |
| 2023 3 | 41 | 19 | 60 |
| 2023 2 | 41 | 23 | 64 |
| 2022 1 | 42 | 36 | 78 |
| 2022 12 | 59 | 33 | 92 |
| 2022 11 | 22 | 28 | 50 |
| 2022 10 | 27 | 30 | 57 |
| 2022 9 | 33 | 27 | 60 |
| 2022 8 | 19 | 30 | 49 |
| 2022 7 | 24 | 35 | 59 |
| 2022 6 | 25 | 29 | 54 |
| 2022 5 | 36 | 36 | 72 |
| 2022 4 | 51 | 46 | 97 |
| 2022 3 | 49 | 60 | 109 |
| 2022 2 | 48 | 43 | 91 |
| 2021 1 | 52 | 40 | 92 |
| 2021 12 | 32 | 42 | 74 |
| 2021 11 | 36 | 47 | 83 |
| 2021 10 | 51 | 59 | 110 |
| 2021 9 | 31 | 40 | 71 |
| 2021 8 | 68 | 34 | 102 |
| 2021 7 | 41 | 22 | 63 |
| 2021 6 | 44 | 26 | 70 |
| 2021 5 | 23 | 31 | 54 |
| 2021 4 | 41 | 31 | 72 |
| 2021 3 | 54 | 29 | 83 |
| 2021 2 | 26 | 24 | 50 |
| 2020 1 | 20 | 21 | 41 |
| 2020 12 | 27 | 18 | 45 |
| 2020 11 | 23 | 9 | 32 |
| 2020 10 | 20 | 3 | 23 |
| 2020 9 | 42 | 5 | 47 |
| 2020 8 | 72 | 24 | 96 |
| 2020 7 | 32 | 12 | 44 |
| 2020 6 | 20 | 22 | 42 |
| 2020 5 | 15 | 15 | 30 |
| 2020 4 | 22 | 18 | 40 |
| 2020 3 | 34 | 17 | 51 |
| 2020 2 | 1 | 4 | 5 |
| 2019 12 | 4 | 2 | 6 |
| 2019 9 | 4 | 1 | 5 |
| 2019 7 | 0 | 2 | 2 |
| 2019 6 | 0 | 6 | 6 |
| 2019 5 | 2 | 26 | 28 |
| 2019 4 | 0 | 1 | 1 |
| 2019 3 | 2 | 9 | 11 |
| 2019 1 | 1 | 0 | 1 |
| 2018 12 | 4 | 0 | 4 |
| 2018 11 | 3 | 0 | 3 |
| 2018 10 | 2 | 0 | 2 |
| 2018 9 | 4 | 0 | 4 |
| 2018 2 | 43 | 6 | 49 |
| 2018 1 | 28 | 6 | 34 |
| 2017 12 | 43 | 7 | 50 |
| 2017 11 | 30 | 4 | 34 |
| 2017 10 | 25 | 4 | 29 |
| 2017 9 | 44 | 11 | 55 |
| 2017 8 | 56 | 14 | 70 |
| 2017 7 | 36 | 8 | 44 |
| 2017 6 | 64 | 12 | 76 |
| 2017 5 | 66 | 4 | 70 |
| 2017 4 | 53 | 9 | 62 |
| 2017 3 | 55 | 25 | 80 |
| 2017 2 | 46 | 18 | 64 |
| 2016 1 | 26 | 6 | 32 |
| 2016 12 | 33 | 6 | 39 |
| 2016 11 | 49 | 9 | 58 |
| 2016 10 | 78 | 20 | 98 |
| 2016 9 | 86 | 6 | 92 |
| 2016 8 | 38 | 8 | 46 |
| 2016 7 | 43 | 20 | 63 |
| 2016 6 | 9 | 14 | 23 |
| 2016 5 | 7 | 0 | 7 |
| 2016 4 | 5 | 2 | 7 |
| 2016 3 | 11 | 1 | 12 |
| 2016 2 | 7 | 1 | 8 |
| 2015 1 | 8 | 0 | 8 |
| 2015 12 | 8 | 3 | 11 |
| 2015 11 | 24 | 4 | 28 |
| 2015 10 | 16 | 2 | 18 |
| 2015 9 | 8 | 1 | 9 |
| 2015 8 | 15 | 2 | 17 |
| 2015 7 | 100 | 2 | 102 |
| 2015 6 | 64 | 11 | 75 |
| 2015 5 | 86 | 9 | 95 |
| 2015 4 | 97 | 12 | 109 |
| 2015 3 | 55 | 5 | 60 |
| 2015 2 | 63 | 9 | 72 |
| 2015 1 | 67 | 14 | 81 |
| 2014 12 | 73 | 13 | 86 |
| 2014 11 | 47 | 10 | 57 |
| 2014 10 | 86 | 14 | 100 |
| 2014 9 | 73 | 14 | 87 |
| 2014 8 | 43 | 9 | 52 |
| 2014 7 | 27 | 6 | 33 |
| 2014 6 | 49 | 6 | 55 |
| 2014 5 | 57 | 6 | 63 |
| 2014 4 | 41 | 1 | 42 |
| 2014 3 | 66 | 9 | 75 |
| 2014 2 | 55 | 7 | 62 |
| 2014 1 | 51 | 9 | 60 |
| 2013 12 | 46 | 9 | 55 |
| 2013 11 | 36 | 9 | 45 |
| 2013 10 | 35 | 8 | 43 |
| 2013 9 | 23 | 8 | 31 |
| 2013 8 | 26 | 14 | 40 |
| 2013 7 | 10 | 15 | 25 |
| 2013 6 | 17 | 16 | 33 |
| 2013 5 | 15 | 8 | 23 |
| 2013 4 | 14 | 9 | 23 |
| 2013 3 | 26 | 6 | 32 |
| 2013 2 | 40 | 3 | 43 |
| 2013 1 | 65 | 6 | 71 |
| 2012 12 | 52 | 5 | 57 |
| 2012 10 | 0 | 1 | 1 |
Mostrar todo
